Attorney General Jeff Sessions made an announcement at a news conference Tuesday that the Justice Department will be creating a new task force to pursue the makers and distributors of prescription opioids. It seems that beyond pursuing new restrictions being put on prescriptions, there will be a more intentional focus on Big Pharma and those who many believe have made the opioid crisis possible.
Jeff Sessions said the task force will “examine existing state and local government lawsuits against opioid manufacturers to determine if we can be of assistance.”
Meanwhile, Sessions also included the Justice Department is going to be backing a lawsuit in Ohio against major prescription opioid makers.
Ohio VS Opioid Makers Lawsuit
In truth, this lawsuit isn’t just about the state of Ohio. It consolidates more than 400 complaints by cities, counties and Native American tribes nationwide. Buckeye Nation has definitely been hit hard by the opioid crisis, but for now, the stage is set here for a massive effort against questionable practices from opioid makers.
The lawsuit that solicits the Justice Departments attention is pending in Federal District Court in Cleveland. It goes after various companies for using misleading marketing to promote prescription opioids, including:
The lawsuit also accuses the defendants of:
- Downplaying the risk of addiction to these drugs
- Failing to report suspicious orders by consumers, which would indicate the drugs were being abused
Furthermore, there are some big names in Big Pharma being listed as defendants, including:
- Johnson & Johnson
- Purdue Pharma
- Teva Pharmaceuticals
The suit is also going after large distributors, such as:
Not to mention pharmacy chains like:
So how will the Justice Department be engaging in the current lawsuit? How will this new development impact the outcome of the case?
For more important information on the dangers of prescription drugs, download our
FREE E-BOOK “Big Secrets of Big Pharma: Why They Secretly Hope You Get Hooked”
DOWNLOAD FREE E-BOOK
Statement of Interest Against Opioid Makers
During the press briefing, Sessions explained that the Justice Department plans to file what is called a “statement of interest” in the Ohio lawsuit. This is a technique that past administrations typically would only resort to in cases that directly affect the federal government’s interests, such as diplomacy and national security.
However, with the intensity of the opioid crisis being what it is, it is perfectly understandable to make it such a high priority for the current administration to get involved with. So far, recovery advocates have been largely unimpressed with the half-measures that have been presented thus far with the Trump administration to address the issue.
By invoking the statement of interest, the attorney general is legally able to argue on behalf of the government’s interest in any court in the country. However, it does not make the government a plaintiff. All things considered, Sessions said his department will use criminal and civil penalties. He states,
“We will use whatever tools we have to hold people accountable for breaking our laws.”
Which is quite a statement, considering it isn’t at all common for criminal charges to be brought against Big Pharma.
The Devil Is in the Data
What brought the Justice Department into this began with a discussion on access to certain data. This past Monday, lawyers for the Drug Enforcement Administration (DEA) came to the Ohio courtroom to discuss how much data they would share about the national distribution of painkillers.
The DEA said it would only provide two years of information in the case, asserting that the agency did not want to compromise ongoing criminal investigations. However, Judge Dan Aaron Polster’s request is to provide the sides with nine years of data. He said the agency has until next Monday to decide whether it will comply. This data can assist in determining:
- The number of pills distributed
- The locations
- The distributors
This information could be crucial in allocating liability.
Richard Fields, a lawyer who represents state attorneys general and sovereign Native American nations in opioid litigation, predicts that the statement of interest from the Justice Department “will help unlock this data so that we can hold manufacturers, distributors and pharmacies accountable for flooding communities with pills.”
Therefore, it appears Sessions is going to be taking some big steps toward calling out Big Pharma for their involvement in the opioid crisis. Sessions says the government will be taking a hard look at doctors who overprescribe prescription painkillers. Even legal drugs like these too often lead to addiction and abuse of illegal drugs like heroin.
Ohio Attorney General Mike DeWine says he believes this is a game changer. With all the suffering communities in Ohio have seen over the past several years, we can only hope.
Holding Big Pharma accountable is a huge step. Nevertheless, we should also highlight the need for state and community officials to promote safe and effective addiction treatment. Innovative and holistic recovery programs can make a dramatic difference in helping heal communities. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398
Over the last 15 years, the suicide rate has climbed by an estimated 32%. While the overdose deaths in relation to the opioid crisis have become a constant issue around the country, some researchers suggest that the real suicide rates are even higher, but some of them are being misclassified as overdoses.
So, are more people dying due to drug abuse, or are more people taking their own lives using powerful street drugs and prescription narcotics?
Studying Suicide and Drugs
The idea that many of the deaths recorded as opioid overdoses may have been suicides, according to the researchers, is due to a significant gap between suicide rates and intoxication mortality rates.
A study from the Luskin School of Public Affairs at the University of California, Los Angeles, was published in the journal PLOS One. This study states that both suicide and drug intoxication death rates in the United States have risen over a period of 15 years. Researchers compiled data from the Center for Disease Control and Prevention (CDC) to show:
- 2000- The suicide rate was 10.40 per 100,000 people
- 2015- Suicide rate rose to 13.75 deaths per 100,000 people
- 2000- Drug intoxication mortality rate for those over the age of 15 was 7.81 deaths per 100,000
- 2015- Drug intoxication death rate for those over the age of 15 rose to 20.07 per 100,000 in 2015
This means that the drug intoxication death rate rose by 257% in those 15 years, while suicide rates only rose by 32%. While 32% is still a devastating number when it comes to such a tragic circumstance, there is still a huge difference between 32% and 257%. These researchers believe this major difference in the reports of mortality rates suggests a lack of suicide reporting.
Difficulties in Death Investigation
One of the big problems, according to the study’s author Mark Kaplan, is resources. Kaplan is a professor of social welfare at UCLA, and he stated to local news sources,
“Unfortunately, part of the problem is due to serious under-resourcing of state and local death investigation systems throughout most of the U.S.
“Many of these deaths were probably suicides, yet reported as accidental self-poisoning rather than intentional self-harm, particularly among the middle-aged.”
The study by Kaplan and his colleagues further explains that when it comes to suicide by overdose, things like an individual’s psychiatric history or the presence of a suicide note are crucial to helping professionals identify a death as a suicide.
“A suicide note, prior suicide attempt or affective disorder was documented in less than one-third of suicides and one-quarter of undetermined deaths,”
“Our incorporation of undetermined deaths, as well as registered suicides, not only provided a window on the nature of suicide misclassification within the undetermined death category but within the accident category—as a much larger reservoir for obscuring drug intoxication suicides.”
So by acknowledging that there is not always an obvious indication that a death is a suicide, even in cases that are classified in suicide, the researchers believe that many deaths that involved drugs have most likely been categorized as overdoses instead of making a deeper inquiry into the circumstances surrounding an individual’s death.
Opioids Causing Ambiguity
With the opioid crisis in America, it has become even more difficult to measure the suicide rates. And that isn’t just this research teams opinion either.
In 2015, the CDC hosted a meeting to address the challenges presented for medical examiners and coroners across the country. The primary focus was concerning cases of fatal intoxication due to opioids and other drugs. The summary of this meeting concluded that drug intoxication deaths may be among the most difficult to determine regarding the manner of death. The summary notes that reasons for such difficulty in having a more accurate manner of death include:
- Potentially equivocal evidence
- Intent to die
- Overlapping demographic groups affected
- Overlapping premorbid risk factors (e.g., substance abuse, mental health problems).
Opioid addiction, much like any other form of substance use disorder, is often closely connected to other issues, including anxiety, trauma and mental health disorders. Some individuals living with mental health conditions who abuse opioids may be self-medicating and accidentally overdose. But others may be suffering so severely, with conditions like depressive disorders or bipolar disorder, that they ultimately take their own lives intentionally with the powerful drugs. With opioid abuse being so widespread and devastating, the line between the two has begun to blur.
Both studies mentioned clearly indicate in order to truly comprehend an accurate number of suicides by overdose, more research is needed. Both also admit that the number may never be exact.
Even though we will probably never have a definitive answer, the question is still important to ask. By knowing whether opioid deaths are caused by accidents or intentional we can develop better strategies to provide education and prevention.
This is also why mental health should always be a priority when it comes to addiction treatment.
Substance use disorder and suicide are both connected to mental health and personal wellness. Too often they both lead to avoidable tragedies. Therefore, mental health and wellness should be a priority for addiction treatment. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now.
CALL NOW 1-888-922-5398
(This content is being used for illustrative purposes only; any person depicted in the content is a model)
The opioid crisis has affected every community in America. Opioids affect rural working class people, those in the inner city and suburbs, or even the wealthy and well-to-do professionals. While drug abuse in business has been highlighted in blockbuster films like the Wolf of Wall Street, the current reality is not far from it. According to addiction experts, substance use disorder is making a sobering impact on the financial industry.
This comes from not just an upscale partying lifestyle, but also from drugs used to manage performance and stress, along with physical pain. According to addiction experts, the financial industry itself is actively turning a blind eye to the issues concerning opioid abuse on Wall Street because money is still the priority, and stigma still gets in the way.
Opioids on Wall Street: White-Collar Confessions
As it stands there is no comprehensive research that takes a detailed look at opioid abuse in Wall Street among finance professionals. So we can’t exactly show the numbers to prove it’s prevalence. However, what we see consistently is a dramatic increase in addiction and overdose rates all over the nation in recent years.
Luckily, professionals from this demographic are beginning to speak out in hopes of progressive change.
One such individual is Trey Laird, a former Wall Street trader, who recently spoke to CNBC about his six-year opioid addiction. During the conversation Laird reiterates the critical understanding that substance use disorder can reach anyone, saying:
“Addiction pervades every single socioeconomic demographic that there is. Every industry, every race, men, women. It doesn’t care who you are,”
After getting clean himself, Laird went on to open a sober living community and says he hopes to specifically serve the Wall Street and white collar demographic.
According to Laird, there has been more talk about opioid addiction among people in higher socioeconomic brackets, but there is still much work that needs to be done. He acknowledges that increasing awareness is doing a great deal, but that the problem is also at an increase. Wall Street may finally be talking about it, but how many professionals will get the help they truly need?
Opioids on Wall Street: Stocks and Stigma
One of the biggest obstacles facing white-collar workers like those in Wall Street is the engrained stigma still attached to addiction. Even with all the shifts in our culture toward a better understanding of substance use and the compassion for those struggling, professionals still have this seemingly unbearable hurdle in front of them.
Truthfully, stigma is something that prevents most people from getting help. Professionals will often be too afraid of losing their jobs to admit they need help. Many in the world of Wall Street and finance may have no information on how to seek out treatment while adhering to their professional boards’ guidelines and business practices.
With white-collar workers, this may be an especially difficult thing because the idea of addiction is so often attached to stereotypes of the unemployable, the homeless, the unreliable and unstable that their high-earning careers might minimize the impact drugs have on their lives. Wall Street stockbrokers and traders might not see themselves as having a problem as long as they can function, which brings in the idea of the “functioning addict.”
Opioids on Wall Street: Function Addiction is Still Addiction
Many white-collar workers who struggle with drugs or alcohol may consider themselves a “functioning addict”, meaning they are less likely see their actions as a problem because they are able to maintain their professional or even personal lives. To make matters worse, frequently the people around someone who is professionally successful will not believe the addiction is real. They may admit that you’ve been careless or destructive in some respects, but will ultimately minimize it due to your financial stability.
As long as you’re making money and paying the bills how could you possibly be “that bad?”
Well, because “functioning addiction” is still an addiction.
Addiction isn’t about whether or not you are able to hold down a steady income. It does not depend on whether or not other people recognize that you have a problem or your competence with your profession. While addiction can and will have an impact on these things, it isn’t always as black and white as most people like to pretend.
Notice how earlier we said you may “maintain” other areas of your life? Well, we mean to say that you can get by for a while, but eventually, the effects of addiction will catch up with you. It could be in the form of serious health consequences or other devastating circumstances. It could take days, months or even years, but it will leave a mark.
Sadly, “functioning addicts” are also far less likely to get the help they desperately need.
Opioids on Wall Street: It Could Be You
While you might be able to keep your addiction secret, in the beginning, things will eventually get worse. Eventually, your addiction will become unmanageable.
If you think you might fit the “functioning addiction” criteria, look at the following questions and answer them honestly.
- Do you often think about using drugs or drinking?
- Do you find it hard to stop after you start drinking or using?
- Are you scheduling your time around drinking or using drugs?
- Have you tried to stop before, but found that you were unable to?
- Do you drink or use drugs first thing in the morning?
- Are you drinking or using drugs at work?
- Do you hide your drug use or drinking?
- Have you done something risky, like driven drunk?
- Do you worry about your drug use or drinking?
If you find you are answering “yes” more than “no” then you should seriously consider speaking with a medical or addiction professional about your drug use or drinking.
The opioid crisis is nothing to be ignored. Despite all that we think we have learned about addiction too many professionals don’t get the help they need. No one is exempt from the destruction of addiction. Opioids don’t care what street you work on, Wall Street or not, they can ruin your life all the same. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398
With the beginning of the new year, Palm Healthcare Company is looking forward to helping spread more exciting stories of experience, strength, and hope while also sharing important news stories and exciting new developments that relate to the world of addiction recovery and substance use disorder treatment. As we commit ourselves to another year of fighting alongside thousands of people working toward a better future, we would also like to take some time looking back on all the big moments in 2017 that we shared with our Palm Healthcare Company Blog.
President Trump Declares Public Health Emergency: What’s the Plan?
October of 2017, President Donald Trump made an announcement declaring the opioid crisis in America as a Public Health Emergency. This highly anticipated declaration was delivered in a way slightly different than many had expected, noting the technical differences between a Public Health Emergency and a National Emergency.
Many advocates were concerned that this announcement did not provide a concrete foundation for the necessary federal funding and did not initiate much-needed action, but others we assured that this means the Trump administration was taking this issue very seriously. In this article, we took a look at what this announcement did actually accomplish, and what it failed to deliver on.
Racketeering for Fentanyl: Opioid Maker Insys Founder Arrested for Bribes
A huge development to another story came in late 2017 when John Kapoor, former CEO of Insys Therapeutics and founding father of one of the most prominent opioid manufacturers in the country, was arrested and charged with conspiring to push the signature drug of Insys Therapeutics, a Fentanyl spray called Subsys, for unacceptable uses through bribes and kickbacks.
The Palm Healthcare Company blog notes how back in 2016 the Justice Department reported to be charging 6 former executives and sales-managers of Insys Therapeutics for conspiring to defraud health insurers.
When looking at the details in this story, it has intensified the conversation about Big Pharma involvement in the epidemic
Can Kellyanne Conway Really Compete with the Opioid Crisis?
Not too long after President Trump’s declaration of a Public Health Emergency pertaining to the opioid crisis, Kellyanne Conway was announced as leading the charge on the White House’s efforts for addressing the opioid epidemic.
This Palm Healthcare Company blog saw a lot of comments!
While some find that having a high-profile figure at the head of the efforts gives validity to the White House’s commitment to solving the opioid issue in America, many others are speaking out in frustration. Those in opposition to this appointment say that while she may be useful as a counselor or pollster, she has no experience of expertise when it comes to drug abuse, addiction or substance use disorder treatment.
Thus far the one thing both Kellyanne and the President seem adamant about is a media campaign, but advocates are still afraid this is more “Just Say No” and not enough support for effective resources.
After Las Vegas Shooting: PTSD and Mental Health Must be Priority
In early October of 2016, the nation was shaken to its core when Las Vegas had one of the deadliest shootings in modern American history. This horrific tragedy flooded newsrooms and live viral footage with the country watching in shock as a gunman killed 58 people and injured 546 more at an outdoor music festival.
In the aftermath of this terrible and heartbreaking incident, our Palm Healthcare Company blog took a look at how such traumatic experiences impact people, and about the importance of those who struggle with Post-traumatic Stress Disorder (PTSD) getting proper diagnosis and care.
At a time when so many people are self-medicating with dangerous or even deadly narcotics, it is important to care for those most vulnerable, especially after such an earth-shattering experience.
Police Helping Addicts into Treatment is a Growing Trend Saving Lives
In August of 2017, we took a look back at several programs that had come to light all over the country based on Police Departments working with their communities to offer drug users the chance to get help with addiction treatment instead of being arrested and charged.
The pioneering program came from Gloucester Police Department in Massachusetts back in 2015. This program allowed users to ask police for help, and told addicts they could submit drugs to local law enforcement without fear of being arrested if they were willing to seek treatment. A 2016 study showed that this program was experiencing some impressive success.
Police departments in a number of other states were inspired by this and took up similar programs as a way to help their communities fight the addiction outbreak.
The Palm Healthcare Company blog took a close look at a handful of these programs to celebrate their compassion and success.
Sterilized for Cash: This Woman Pays Drug Addicts to Not Have Kids
Pregnant lady’s stomach and her hand holding dollar over black background
When we posted this Palm Healthcare Company blog we saw a great deal of debate in the comments on our Facebook. For over 20 years, Barbara Harris has driven across the country using cash to ask addicted women to give up their fertility. To date, the organization has paid over 7,000 people.
The controversy around such a powerful story had some people showing a great deal of support for someone giving addicted women an incentive to not get pregnant, while other people were appalled and angered that someone would entice desperate women who are not in the right mindset to make such dramatic and life-altering decisions with their bodies.
What Chester Bennington Taught Us about Addiction and Depression
(This content is being used for illustrative purposes only; any person depicted in the content is a model)
In July of 2017, the world lost a great artist and inspirational musician with the death of Chester Bennington, the lead singer of the band Linkin Park.
Initial reports were that Bennington had died from suicide by hanging, with later reports indicating that Chester had been drinking at the time of his death. The vocalist had been open about his struggles with depression and drug addiction over the years, and in this article, we took a look at just how much Chester Bennington could teach us about the devastation of depression and addiction.
Dear Media, Thank You for Bad Press
South Florida has been under a great deal of scrutiny recently, specifically concerning the issues facing the recovery community such as unethical and illegitimate sober home operators in the area. In June, there was a Megyn Kelly NBC News Investigation which focused in on Delray Beach, Florida and some of the big problems concerning unscrupulous activities from corrupt individuals exploiting drug addicts in need of help.
We took this time to look over some of the bigger stories concerning the illicit activities in South Florida with the recovery industry while showing support and gratitude for all those working together to try and put an end to operators who are taking advantage of people in need of help.
Palm Healthcare Measures Up to Addiction Treatment Outline for EAP
In September of 2017, we took a very close look at an article written by the Journal of Employee Assistance that was designed to help Employee Assistance Programs (EAPs) find the right kind of addiction treatment programs to recommend to their clients.
The outline given for EAPs to find effective and reliable addiction treatment options gives a list of things to look for. The Palm Healthcare Company blog was happy to show off just how all of our facilities measure up to these crucial standards.
Keep an Eye Out for More
Palm Healthcare Company continues to try and share every treatment development, news story or exciting innovation on our blog to not only help more people learn and raise awareness but to offer some perspective and maybe ask some new questions.
Whether it is sports, celebrities, news or politics we are committed to talking about important stories that pertain to drug policy in America, substance use disorder, mental health, and personal wellness. We will continue to touch on the top stories of 2018 to spread the word and hopefully inspire more people to get involved in these crucial conversations.
2017 was an intense, innovative and inspiring year. Here is to hope for 2018.
Holistic addiction treatment means incorporating every aspect of life for each individual with personalized opportunities for lasting recovery. So every bit of information can help anyone make a more comprehensive decision about what kind of recovery plan they want. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398
This past Wednesday, Attorney General Jeff Sessions made the announcement that White House counselor Kellyanne Conway will be the Trump administration’s go-to for opioid crisis efforts. This announcement has been met with both praise and criticism. Some say this appointment actually gives validity to the White House’s commitment to solving the ongoing opioid epidemic, while others see it as the exact opposite.
For a little background, Kellyanne Conway worked as a pollster before becoming Trump’s campaign manager during his run for the 2016 presidential nomination. Currently, Conway serves as a White House spokeswoman and Trump surrogate. She has been seen on countless panels discussing the biggest topics and politics. She absolutely has her work cut out for her, so can Kellyanne Conway compete?
The Kellyanne Cons and Pros
So can this infamous Trump advocate, the woman who practically accidentally coined the phrase “alternative facts” compete with the opioid crisis in America? Kallyanne Conway has become notorious for defending some of President Trump’s most flagrant and controversial “alternative facts” in the media. But in her defense, she also has said some things that seem to highlight important prospects for this problem.
So here are some things to consider when we talk about Kellyanne Conway being put in charge of the opioid epidemic.
Lack of Experience
One of the big problems with this appointment people are pointing out is the lack of experience. Critics say this appointment speaks to how little passion the current administration is actually putting into fighting the opioid crisis since Kellyanne Conway has no experience in public health or with drug policy.
But in a time where Americans seem to be putting more trust in people that don’t typically meet the description of “qualified” in hopes that an outsider might bring better results, it makes sense that a lot of people might still hope Kellyanne can do some good.
Yet, there are still those who aren’t so sure. Tom Synan, a police chief and member of the Hamilton County Heroin Coalition in Ohio tweeted in response to the announcement:
“Ummm… did we run out of Dr’s, cops, addiction specialists or people who are actually dealing with this on the street to lead this?”
As a first responder, Synan is one of many people who are frustrated with the current actions being taken.
“I don’t want to get involved in politics, but it seems like it is a political position … I think I would have gone out to the country and tapped into people who are national experts who are on the street who are literally dealing with this issue every day,”
It seems many on the front lines are not impressed with the Trump administration’s move to put Kellyanne Conway in charge of efforts to combat one of the worst drug problems in the nation’s history.
Publicity and Perception
During a press briefing about the Justice Department’s efforts to combat the crisis where the announcement was made, Sessions said President Donald Trump chose Kellyanne Conway to “change the perception” about opioids and reduce addictions and deaths.
According to Sessions, President Trump has made the epidemic “a top priority for his administration, including every senior official and Cabinet member.”
An opioid policy expert Andrew Kolodny of Brandeis University actually defended the move when speaking to BuzzFeed News, stating:
“It is a positive sign. She is a high-profile figure in the administration, showing the administration takes this seriously,”
Some believe this can offer a sign of hope for more concrete action since many recovery advocates say despite the declaration of a public health emergency from President Trump there has been very little action taken to change the state of the epidemic.
Bertha Madras, a member of the President’s Commission on Combating Drug Addiction and the Opioid Crisis and Harvard Medical School professor, said:
“The most important thing that Kellyanne Conway will provide is access … but also commitment… She was at all the meetings, she listened and took copious notes.”
Let’s hope those are some good notes because thus far the opioid problem in America has shown no signs of slowing down. Jeff Sessions justified the appointment by saying Kellyanne Conway “understanding messaging” and can help turn around public perception. But is this about publicity, or is it about the preservation of life?
Surely breaking the stigma and changing the way addiction is viewed does matter, but should someone who specializes in making things look good to be in charge of how this country deals with one of the most prominent crises we face?
Treatment and Resources
Kellyanne does seem to support treatment, but to what extent it is still unclear. In one interview with ABC Kellyanne Conway did say,
“Pouring money into the problem is not the only answer. We have to get serious about in-facility treatment and recovery.”
So she at least appears to understand how crucial effective inpatient treatment is for recovery.
But when reporters mentioned the fact that there needs to be funding for these programs, she put more emphasis on “a 4 letter word called will” that seems to side-step the question- where will these resources come from?
As it now stands, White House has:
- Left the leadership role of the Office of National Drug Control Policy vacant
- Failed to release any written opioid-control strategy
- Not requested funds to replenish the national public health emergency fund that currently sits at just $66,000
In fact, President Trump’s 2018 budget request would increase addiction treatment funding by less than 2%. And don’t be fooled, that increase includes the $500 million already appropriated by Congress in 2016 under the 21st Century Cures Act with the Obama administration.
Even Chris Christie, the Republican New Jersey Governor who led the White House Opioid Commission, said:
“In New Jersey, we are spending $500 million,” he said. “I am not, quite frankly, impressed with $1 billion from the federal government for the nation.”
Strict Prevention and Punishment
When you look at what she has said on record in regards to opioids and addiction, it doesn’t really inspire a great deal of confidence. Kellyanne Conway has consistently hinted to an outdated ideology of what addiction is and how to address it.
In the past, Kellyanne has said,
“The best way to stop people dying from overdoses and drug abuse is by not starting in the first place… That’s a big core message for our youth.”
That’s right; just say no.
Critics say this aligns with the mindset of Jeff Sessions and others in the White House who seem to think that ‘Just Say No’ tactics actually work, or that purely prevention-based programs like D.A.R.E. can solve the whole problem. While prevention is important, it has proven to be ineffective as a focal point when addressing addiction.
Circling back to publicity, what Ms. Conway does seem to heavily endorse is a White House investigation for a “national ad campaign” on abuse prevention. President Trump himself had voiced his own support for a national advertising initiative to try and deter drug use.
But we all remember those commercials- this is your brain on drugs- and they didn’t really help that much.
Again, it seems Attorney General Sessions and the current administration is more focused on punishment than treatment and strict law enforcement. Sessions said the Justice Department was giving more than $12 million in grants to state and local law enforcement to help them prosecute crimes connected to:
Sessions is also ordering all U.S. Attorney offices to designate opioid coordinators. Kaitlyn Boecker, Policy Manager with the Drug Policy Alliance, has been vocal in her disapproval of the current steps being taken.
“Despite declaring the opioid overdose crisis a public health emergency just last month, the Trump Administration continues to emphasize failed prohibitionist policies while ignoring proven public health measures that we know reduce overdose death, like community naloxone distribution.”
“As we feared, the Administration is using the overdose crisis as an excuse to ratchet up the war on drugs rather than an opportunity to save lives.”
At this point, we can say that the news is not without skeptics. While many are still trying to remain hopeful that maybe because Kellyanne is so vocal and such a well-known surrogate for the president that perhaps she will be able to garner more attention to the issue.
While the fight for more resources continues, we should always encourage people to seek help. There are many safe and effective treatment resources already that have been helping people recover from drug and alcohol addiction for decades, like Palm Healthcare Company. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398
Support for Medication-Assisted Treatment (MAT) has continued to grow in recent years as the opioid epidemic in America has put a mounting strain on the country. While the numbers of overdoses and opioid-related deaths have steadily climbed to devastating heights there has been more effort to explore treatment options. A better understanding of the medical and mental health aspects of addiction has become a priority. Stigma has slowly begun to carry less weight while advocates push for more effective and supportive routes to care for recovering addicts. One thing people have turned to heavily is medications like Suboxone of Methadone in attempts to steer away from more illicit and dangerous substances like heroin or fentanyl.
The application of medication in treatment can be very useful. It is a strategy that can help with the preservation of life by helping people stay off more unpredictable and life-threatening substances. However, some would say that if used for long-term this form of treatment is still relying on the idea of substitution. Often times these drugs have their own very harsh withdrawal symptoms, especially with extended use.
Taking a look at the more popular drugs used for medication-assisted treatment, one may ask- can you quit medication-assisted treatment with no withdrawals?
Understanding Medication-Assisted Treatment
Medication Assisted Treatment is the use of anti-craving medications to try and help address issues related to drug dependence, withdrawal, and relapse. The more common medications used in MAT include:
But MAT is also utilized alongside comprehensive therapy and other forms of support. Experts and advocates for addiction recovery, including the Substance Abuse and Mental Health Services Administration (SAMHSA), insist that maintenance medications alone are not sufficient enough treatment.
Advocates for medication-assisted treatment will compare MAT to someone taking medication for diabetes or asthma, with the belief that maintenance drugs are an essential part of staying healthy. However, others in the world of addiction recovery still believe it is possible to be healthy in recovery without the prolonged use of powerful medications.
The truth is the answer may not be the same for everybody. Different treatments may be more useful for different people. No one should be ashamed of the method they use to get help. But we also want to look at how some drugs used in medication-assisted treatment might make things more complicated for certain people.
Looking at the most popular maintenance drugs for opioid addiction, of course, we find Suboxone. To better understand Suboxone withdrawals, we first have to know what it is. This popular brand name is used to identify a prescription medication that contains active ingredients:
- Buprenorphine- a narcotic opioid medication
- Naloxone– an opioid blocker that impedes the effect of opioid medications
This medication functions as a partial opioid agonist and diminishes cravings as well as prevents other opioids from reacting to the brain’s opioid receptors. Taken in low doses for short periods of time, the drug can be helpful in curbing opioid withdrawal symptoms while tapering off without too many residual effects.
The tricky part comes when someone uses Suboxone for an extended amount of time as a replacement for heroin or other opioids.
Sometimes this can lead to its own form of recreational use and physical dependence. Even the U.S. Drug Enforcement Administration reports that Suboxone is commonly susceptible to abuse. It is still a powerful drug.
Suboxone Withdrawal Symptoms
While Suboxone and other maintenance drugs may be a preferred tactic for going ‘cold turkey’ off of heroin or other opioids, the drug itself still has the power to cause its own set of withdrawal symptoms. These symptoms can include:
- Irritability or agitation
- Difficulty sleeping
- Profuse sweating
- Runny nose
- Frequent yawning
- Stomach pain or cramping
- Dilated pupils
- Nausea and vomiting
- Changes in mood
Not to mention precipitated withdrawal, when the ingredients in this medication can actually induce the onset of unpleasant symptoms rapidly, if not immediately, for someone actively engaged in opioid use.
Methadone is a long-acting opioid medication utilized since the 1970s to try and help people get off of heroin. It is typically used today under strict medical supervision because the drug is very potent and has a high risk of addiction. In fact, a 2012 National Survey on Drug Use and Health found that approximately 2.46 million people reported to using methadone for a non-prescribed purpose at least once.
According to another study, in 2009 methadone was responsible for 1 out of every 3 opioid overdose deaths.
Because of the risks, a gradual taper should be utilized to wean someone off of methadone. Often times doctors will prescribe another detox medication to help with this process, with the tapering to be done under medical supervision.
But as with trying to quit heroin or other powerful opioids ‘cold turkey’, trying to abruptly discontinue methadone can bring on intense withdrawal. This includes physical and psychological symptoms such as:
- Runny nose
- Tearing or watery eyes
- Muscle aches
- Joint pain
- Abdominal cramps
Many of these symptoms are similar to the symptoms of withdrawing from heroin or other opioids. So in a sense, this drug can create similar withdrawal symptoms as the drugs it is supposed to be used to treat.
Quitting Medication Assisted Treatment
Is it possible to quit medication-assisted treatment- yes, there are always other options for getting comprehensive care and lasting recovery without the prolonged use of these medications. Even relapse prevention is possible without relying on medications to fight cravings.
Can you quit medication-assisted treatment with no withdrawals? Well, that may be a process. It depends on a number of factors, such as the specific maintenance medication and the length of time using it. For example, someone who has been using methadone for years could probably have a much harder time getting off methadone than someone who used another medication for a month or so to help get off opioids.
Safety is crucial when deciding to quit MAT. Quitting medication-assisted treatment without a taper or other forms of medication can cause intense withdrawals. It is not suggested that someone try to quit MAT ‘cold turkey’ or without consulting a doctor for help with changing the dosage and slowly tapering off the drugs.
Again, just because it isn’t heroin or fentanyl doesn’t make it harmless.
MAT or Detox?
Medication-assisted treatment holds a lot of value, but the question becomes whether or not it is the kind of sustainable solution you want. Recovery isn’t one-size-fits-all. Medication-assisted treatment can be helpful in saving someone’s life who cannot stop using drugs. But is it something that will completely eliminate cravings and withdrawals, or will it just postpone these symptoms?
Remember, these are still powerful narcotic drugs that have a high risk for abuse. Some people end up using medication maintenance for life. Others will use it for a short period of time, with a detox period afterward. Either way, it is your choice; how long do you want to rely on substances, and to what extent?
Other models believe in providing holistic treatment and personalized therapy after a detox period, helping to reduce and remove chemical dependence and build a foundation for personal recovery.
Using medication to help with the painful and often overwhelming symptoms of withdrawal from opioids and other drugs can be essential to a smooth and healthy transition. In fact, with a safe medical detox, each individual is given an initial assessment to see what medications will be helpful in making this phase of treatment comfortable and safe. This can include medications for anxiety, mood disorders, physical pains and various other side-effects of substance abuse.
And when it comes to some of these medications, it can sometimes be necessary to continue using them.
The biggest difference is whether narcotic maintenance medications like Suboxone or methadone become a long-term prerequisite to recovery, or if they are used to help someone who is sick get better so that the real healing can happen.
Palm Healthcare Company believes in providing a safe medical detox to allow for a comfortable and healthy transition from active drug or alcohol use. Our facilities utilize an experienced and professional medical staff who help to monitor each individual’s progress and provide effective medical support for lasting recovery. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398